{"id":296,"date":"2026-01-07T14:59:56","date_gmt":"2026-01-07T19:59:56","guid":{"rendered":"https:\/\/elyxaminos.com\/?post_type=product&#038;p=296"},"modified":"2026-07-27T09:33:31","modified_gmt":"2026-07-27T14:33:31","slug":"semaglutide-5mg","status":"publish","type":"product","link":"https:\/\/elyxaminos.com\/en\/producto\/semaglutide-5mg\/","title":{"rendered":"Semaglutide 5mg"},"content":{"rendered":"<section class=\"acordeon\">\n<details open=\"open\">\n<summary>\ud83d\udd39 PERFIL CIENT\u00cdFICO EN PROFUNDIDAD<\/summary>\n<p>Semaglutide es un an\u00e1logo sint\u00e9tico del p\u00e9ptido-1 similar al glucag\u00f3n (GLP-1) con una homolog\u00eda del 94% respecto al GLP-1 humano nativo. Este p\u00e9ptido de 31 amino\u00e1cidos (PM: 4113.58 Da) incorpora modificaciones estrat\u00e9gicas que prolongan su vida media:<\/p>\n<p><strong>Modificaciones Estructurales:<\/strong><\/p>\n<p>Sustituci\u00f3n de Alanina por \u00c1cido 2-aminoisobut\u00edrico (AIB) en posici\u00f3n 8<br \/>\nAcilaci\u00f3n en Lisina-26 con \u00e1cido graso C18 mediante espaciador<br \/>\nCadena lateral hidrof\u00f3bica que facilita uni\u00f3n a alb\u00famina s\u00e9rica (&gt;99%)<\/p>\n<p><strong>Mecanismos Moleculares:<\/strong><\/p>\n<ul>\n<li><strong>Receptor GLP-1R:<\/strong> Activaci\u00f3n selectiva en c\u00e9lulas \u03b2 pancre\u00e1ticas, hipot\u00e1lamo y tracto gastrointestinal<br \/>\nV\u00eda cAMP\/PKA: Incremento de AMP c\u00edclico intracelular \u2192 secreci\u00f3n insul\u00ednica glucosa-dependiente<\/li>\n<li><strong>Supresi\u00f3n de Glucag\u00f3n:<\/strong> Inhibici\u00f3n de c\u00e9lulas \u03b1 pancre\u00e1ticas durante hiperglucemia<br \/>\nVaciamiento G\u00e1strico: Retraso mediado por se\u00f1alizaci\u00f3n vagal (reducci\u00f3n 70%)<\/li>\n<li><strong>Saciedad Central:<\/strong> Activaci\u00f3n de neuronas POMC\/CART en n\u00facleo arcuato hipotal\u00e1mico<\/li>\n<\/ul>\n<p><strong>Farmacocin\u00e9tica Avanzada:<\/strong><\/p>\n<ul>\n<li><strong>Biodisponibilidad subcut\u00e1nea:<\/strong> 89%<\/li>\n<li><strong>Tm\u00e1x:<\/strong> 1-3 d\u00edas post-inyecci\u00f3n<\/li>\n<li><strong>Vida media:<\/strong> 165-184 horas (administraci\u00f3n semanal)<\/li>\n<li><strong>Clearance renal:<\/strong> &lt;1% (degradaci\u00f3n proteol\u00edtica primaria)<\/li>\n<li><strong>Estado estacionario:<\/strong> 4-5 semanas<\/li>\n<\/ul>\n<\/details>\n<details>\n<summary>\ud83d\udd39 APLICACIONES, MECANISMOS E INVESTIGACI\u00d3N EXTENDIDA<\/summary>\n<p><strong>Regulaci\u00f3n Metab\u00f3lica en Modelos Experimentales<\/strong><br \/>\n<strong>Control Gluc\u00e9mico:<\/strong><\/p>\n<ul>\n<li><strong>Reducci\u00f3n de HbA1c:<\/strong> 1.5-2.0% en modelos diab\u00e9ticos (Aroda et al., 2017)<\/li>\n<li><strong>Incremento secreci\u00f3n insul\u00ednica:<\/strong> 200-300% durante pruebas de tolerancia oral<\/li>\n<li><strong>Mejora sensibilidad insul\u00ednica:<\/strong> \u00edndice HOMA-IR reducido 40-50%<\/li>\n<\/ul>\n<p><strong>Modulaci\u00f3n del Peso Corporal:<\/strong><\/p>\n<ul>\n<li><strong>Reducci\u00f3n peso:<\/strong> 12-15% en estudios prolongados (68 semanas) (Wilding et al., 2021)<\/li>\n<li><strong>P\u00e9rdida grasa visceral:<\/strong> 25-30% superior a tejido subcut\u00e1neo<\/li>\n<li><strong>Preservaci\u00f3n masa magra:<\/strong> 85-90% de p\u00e9rdida corresponde a tejido adiposo<\/li>\n<\/ul>\n<p><strong>Efectos Cardiovasculares (Estudios SUSTAIN):<\/strong><\/p>\n<ul>\n<li><strong>Reducci\u00f3n eventos MACE:<\/strong> 26% vs placebo (Marso et al., 2016)<\/li>\n<li><strong>Disminuci\u00f3n presi\u00f3n arterial sist\u00f3lica:<\/strong> 4-6 mmHg<\/li>\n<li><strong>Mejora perfil lip\u00eddico:<\/strong> reducci\u00f3n triglic\u00e9ridos 15-20%<\/li>\n<\/ul>\n<p><strong>Neuroprotecci\u00f3n y Funci\u00f3n Cognitiva<\/strong><\/p>\n<p><strong>Modelos de Neurodegeneraci\u00f3n:<\/strong><\/p>\n<ul>\n<li><strong>Reducci\u00f3n placas \u03b2-amiloide en modelos Alzheimer:<\/strong> 30-40% (Cai et al., 2018)<\/li>\n<li>Prevenci\u00f3n p\u00e9rdida neuronal dopamin\u00e9rgica en Parkinson<\/li>\n<li><strong>Atenuaci\u00f3n neuroinflamaci\u00f3n:<\/strong> disminuci\u00f3n IL-6, TNF-\u03b1 (50-60%)<\/li>\n<\/ul>\n<p><strong>Plasticidad Sin\u00e1ptica:<\/strong><\/p>\n<ul>\n<li><strong>Incremento BDNF (Factor Neurotr\u00f3fico Derivado del Cerebro):<\/strong> 25-35%<\/li>\n<li>Mejora potenciaci\u00f3n a largo plazo (LTP) hipocampal<\/li>\n<li><strong>Neurog\u00e9nesis en giro dentado:<\/strong> aumento 40%<\/li>\n<\/ul>\n<\/details>\n<details>\n<summary>\ud83d\udd39 PROTOCOLOS AVANZADOS DE INVESTIGACI\u00d3N<\/summary>\n<p><b>Dosificaci\u00f3n en Modelos Animales<\/b><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Especie<\/b><\/td>\n<td><b>Aplicaci\u00f3n<\/b><\/td>\n<td><b>Rango Dosificaci\u00f3n<\/b><\/td>\n<td><b>Frecuencia<\/b><\/td>\n<td><b>V\u00eda<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">Ratones<\/span><\/td>\n<td><span style=\"font-weight: 400\">Control gluc\u00e9mico<\/span><\/td>\n<td><span style=\"font-weight: 400\">5-20 nmol\/kg<\/span><\/td>\n<td><span style=\"font-weight: 400\">Semanal<\/span><\/td>\n<td><span style=\"font-weight: 400\">SC<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">Ratas<\/span><\/td>\n<td><span style=\"font-weight: 400\">Reducci\u00f3n peso<\/span><\/td>\n<td><span style=\"font-weight: 400\">10-50 nmol\/kg<\/span><\/td>\n<td><span style=\"font-weight: 400\">Semanal<\/span><\/td>\n<td><span style=\"font-weight: 400\">SC<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">Primates<\/span><\/td>\n<td><span style=\"font-weight: 400\">Estudios cardiovasculares<\/span><\/td>\n<td><span style=\"font-weight: 400\">2-10 nmol\/kg<\/span><\/td>\n<td><span style=\"font-weight: 400\">Semanal<\/span><\/td>\n<td><span style=\"font-weight: 400\">SC<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h4><b>Estudios In Vitro<\/b><\/h4>\n<p><b>Cultivos Celulares:<\/b><\/p>\n<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\"><strong>C\u00e9lulas \u03b2 pancre\u00e1ticas (INS-1):<\/strong> 1-100 nM en medio completo.<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\"><strong>Neuronas primarias:<\/strong> 10-50 nM con exposici\u00f3n 48-72h.<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\"><strong>Adipocitos 3T3-L1:<\/strong> 5-25 nM durante diferenciaci\u00f3n.<\/span><\/li>\n<\/ul>\n<\/details>\n<details>\n<summary>\ud83d\udd39 M\u00c9TODOS DE RECONSTITUCI\u00d3N OPTIMIZADOS<\/summary>\n<p><b>Protocolo Est\u00e1ndar:<\/b><\/p>\n<ol>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Utilizar agua bacteriost\u00e1tica est\u00e9ril (pH 7.0-7.4)<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Para vial 5mg: agregar 2.0mL \u2192 concentraci\u00f3n 2.5mg\/mL<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Inyectar lentamente por pared del vial (evitar espuma)<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Rotar suavemente 30-60 segundos (NO agitar vigorosamente)<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Verificar soluci\u00f3n transparente sin part\u00edculas<\/span><\/li>\n<\/ol>\n<p><b>Almacenamiento Post-Reconstituci\u00f3n:<\/b><\/p>\n<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Refrigeraci\u00f3n: 2-8\u00b0C por hasta 56 d\u00edas<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Proteger de luz directa (viales \u00e1mbar recomendados)<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Evitar congelaci\u00f3n completa (&lt;-20\u00b0C)<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Permitir equilibrio temperatura ambiente antes de administraci\u00f3n<\/span><\/li>\n<\/ul>\n<\/details>\n<details>\n<summary>\ud83d\udd39 PREGUNTAS FRECUENTES DE INVESTIGACI\u00d3N<\/summary>\n<p><b>P: \u00bfC\u00f3mo se compara Semaglutide con otros agonistas GLP-1?<\/b><span style=\"font-weight: 400\"> R: Presenta mayor afinidad por GLP-1R (EC50: 0.38 nM vs 1-5 nM de liraglutide) y vida media 7 veces superior, permitiendo administraci\u00f3n semanal vs diaria.<\/span><\/p>\n<p><b>P: \u00bfEs compatible con investigaci\u00f3n en combinaci\u00f3n con insulina?<\/b><span style=\"font-weight: 400\"> R: S\u00ed, estudios demuestran sinergia en control gluc\u00e9mico con reducci\u00f3n 30% de dosis insul\u00ednica necesaria (Aroda et al., 2017).<\/span><\/p>\n<p><b>P: \u00bfQu\u00e9 marcadores bioqu\u00edmicos monitorear en estudios prolongados?<\/b><span style=\"font-weight: 400\"> R: Glucosa plasm\u00e1tica, HbA1c, p\u00e9ptido C, glucag\u00f3n, lipasa s\u00e9rica, funci\u00f3n renal (creatinina, BUN), y marcadores inflamatorios (PCR, IL-6).<\/span><\/p>\n<p><b>P: \u00bfCu\u00e1l es el tiempo \u00f3ptimo para evaluaciones metab\u00f3licas?<\/b><span style=\"font-weight: 400\"> R: Estado estacionario alcanzado en 4-5 semanas; mediciones gluc\u00e9micas continuas requieren al menos 8 semanas para efectos completos.<\/span><\/p>\n<\/details>\n<details>\n<summary>\ud83d\udd39 REFERENCIAS DE INVESTIGACI\u00d3N<\/summary>\n<ol>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Aroda VR, et al. (2017) &#8220;Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine&#8221; &#8211; <\/span><i><span style=\"font-weight: 400\">Lancet Diabetes Endocrinol<\/span><\/i><span style=\"font-weight: 400\"> 5(5):355-366. [PubMed: 28344112]<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Wilding JPH, et al. (2021) &#8220;Once-Weekly Semaglutide in Adults with Overweight or Obesity&#8221; &#8211; <\/span><i><span style=\"font-weight: 400\">N Engl J Med<\/span><\/i><span style=\"font-weight: 400\">384(11):989-1002. [PubMed: 33567185]<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Marso SP, et al. (2016) &#8220;Semaglutide and Cardiovascular Outcomes in Diabetes&#8221; &#8211; <\/span><i><span style=\"font-weight: 400\">N Engl J Med<\/span><\/i><span style=\"font-weight: 400\"> 375(19):1834-1844. [PubMed: 27633186]<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Cai HY, et al. (2018) &#8220;GLP-1 treatment protects Alzheimer model through enhancing neuronal insulin signaling&#8221; &#8211; <\/span><i><span style=\"font-weight: 400\">Brain Res<\/span><\/i><span style=\"font-weight: 400\"> 1678:64-72. [PubMed: 29128461]<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Novo Nordisk Research (2017) &#8220;Pharmacokinetic properties of semaglutide&#8221; &#8211; <\/span><i><span style=\"font-weight: 400\">Diabetes Obes Metab<\/span><\/i><span style=\"font-weight: 400\"> 19(1):140-147.<\/span><\/li>\n<\/ol>\n<\/details>\n<details>\n<summary>\ud83d\udd39 Certificado COA<\/summary>\n<p>\nEste navegador no soporta iframes. Puedes descargar el PDF aqu\u00ed:<br \/>\n<a href=\"https:\/\/elyxaminos.com\/wp-content\/uploads\/2026\/02\/SEMA_Elyx2512160143_COA.pdf\" target=\"_blank\" rel=\"noopener\">Descargar PDF<\/a>.\n<\/p>\n<\/details>\n<details>\n<summary>\ud83d\udd39 Certificado Endotoxins<\/summary>\n<p>\nEste navegador no soporta iframes. Puedes descargar el PDF aqu\u00ed:<br \/>\n<a href=\"https:\/\/elyxaminos.com\/wp-content\/uploads\/2026\/02\/SEMA_Elyx2512160144_ENDO.pdf\" target=\"_blank\" rel=\"noopener\">Descargar PDF<\/a>.\n<\/p>\n<\/details>\n<p style=\"margin-top:16px\"><strong>Material de investigaci\u00f3n \u00fanicamente.<\/strong> Este producto est\u00e1 destinado exclusivamente a investigaci\u00f3n cient\u00edfica en entornos de laboratorio controlados. No es un medicamento. <strong>No para uso humano ni animal<\/strong>, ni para uso diagn\u00f3stico o terap\u00e9utico.<\/p>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<ul>\n<li>Agonista del receptor GLP-1 para investigaci\u00f3n metab\u00f3lica avanzada.<\/li>\n<li>Apoya el control del apetito y la regulaci\u00f3n gluc\u00e9mica.<\/li>\n<li>Contribuye al estudio de la sensibilidad a la insulina y el metabolismo energ\u00e9tico.<\/li>\n<li>Compuesto de alta pureza, dise\u00f1ado exclusivamente para fines de investigaci\u00f3n.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<div style=\"display: flex; flex-wrap: wrap; gap: 4px;justify-content: center\"><a href=\"https:\/\/elyxaminos.com\/wp-content\/uploads\/2026\/02\/SEMA_Elyx2512160143_COA.pdf\" target=\"_blank\" rel=\"noreferrer\"><br \/>\n<button style=\"display: flex; align-items: center; justify-content: center; background: linear-gradient(264.62deg, #02042B 11.77%, #0334D8 62.3%, #48DFE4 91.88%); padding: 15px 30px; border-radius: 50px; color: white; border: none; font-weight: bold; cursor: pointer; text-align: center; font-family: sans-serif; min-width: 150px;\"> Certificate of Analysis<br \/>\n<\/button><br \/>\n<\/a><br \/>\n<a href=\"https:\/\/elyxaminos.com\/wp-content\/uploads\/2026\/02\/SEMA_Elyx2512160144_ENDO.pdf\" target=\"_blank\" rel=\"noreferrer\"><br \/>\n<button style=\"display: flex; align-items: center; justify-content: center; background: linear-gradient(264.62deg, #02042B 11.77%, #0334D8 62.3%, #48DFE4 91.88%); padding: 15px 30px; border-radius: 50px; color: white; border: none; font-weight: bold; cursor: pointer; text-align: center; font-family: sans-serif; min-width: 150px;\"> Endotoxins<br \/>\n<\/button><br \/>\n<\/a><\/div>","protected":false},"featured_media":1594,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[37,38,41],"product_tag":[],"class_list":{"0":"post-296","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-fat-loss","7":"product_cat-body-recomp","8":"product_cat-metabolic-health","10":"first","11":"instock","12":"shipping-taxable","13":"purchasable","14":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/product\/296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/comments?post=296"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/media\/1594"}],"wp:attachment":[{"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/media?parent=296"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/product_brand?post=296"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/product_cat?post=296"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/product_tag?post=296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}